O'Meara MM - Search Results

1

Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Futscher BW, O'Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM, Seftor RE, Hendrix MJ, Domann FE. Futscher BW, et al. Neoplasia. 2004 Jul-Aug;6(4):380-9. doi: 10.1593/neo.04115. Neoplasia. 2004. PMID: 15256060 Free PMC article.

2

Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease.

Lai LW, Whitehair O, Wu MJ, O'Meara M, Lien YH. Lai LW, et al. Clin Genet. 2003 Jun;63(6):476-82. doi: 10.1034/j.1399-0004.2003.00077.x. Clin Genet. 2003. PMID: 12786754

3

Cis-regulatory mutations in the Caenorhabditis elegans homeobox gene locus cog-1 affect neuronal development.

O'Meara MM, Bigelow H, Flibotte S, Etchberger JF, Moerman DG, Hobert O. O'Meara MM, et al. Genetics. 2009 Apr;181(4):1679-86. doi: 10.1534/genetics.108.097832. Epub 2009 Feb 2. Genetics. 2009. PMID: 19189954 Free PMC article.

4

A left/right asymmetric neuronal differentiation program is controlled by the Caenorhabditis elegans lsy-27 zinc-finger transcription factor.

Zhang F, O'Meara MM, Hobert O. Zhang F, et al. Among authors: o meara mm. Genetics. 2011 Jul;188(3):753-9. doi: 10.1534/genetics.111.129064. Epub 2011 May 9. Genetics. 2011. PMID: 21555395 Free PMC article.

5

Genetic screens for Caenorhabditis elegans mutants defective in left/right asymmetric neuronal fate specification.

Sarin S, O'Meara MM, Flowers EB, Antonio C, Poole RJ, Didiano D, Johnston RJ Jr, Chang S, Narula S, Hobert O. Sarin S, et al. Genetics. 2007 Aug;176(4):2109-30. doi: 10.1534/genetics.107.075648. Genetics. 2007. PMID: 17717195 Free PMC article.

6

Caenorhabditis elegans mutant allele identification by whole-genome sequencing.

Sarin S, Prabhu S, O'Meara MM, Pe'er I, Hobert O. Sarin S, et al. Nat Methods. 2008 Oct;5(10):865-7. doi: 10.1038/nmeth.1249. Epub 2008 Aug 1. Nat Methods. 2008. PMID: 18677319 Free PMC article.

7

Maintenance of neuronal laterality in Caenorhabditis elegans through MYST histone acetyltransferase complex components LSY-12, LSY-13 and LIN-49.

O'Meara MM, Zhang F, Hobert O. O'Meara MM, et al. Genetics. 2010 Dec;186(4):1497-502. doi: 10.1534/genetics.110.123661. Epub 2010 Oct 5. Genetics. 2010. PMID: 20923973 Free PMC article.

8

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.

Fathi AT, Erba HP, Lancet JE, Stein EM, Ravandi F, Faderl S, Walter RB, Advani AS, DeAngelo DJ, Kovacsovics TJ, Jillella A, Bixby D, Levy MY, O'Meara MM, Ho PA, Voellinger J, Stein AS. Fathi AT, et al. Among authors: o meara mm. Blood. 2018 Sep 13;132(11):1125-1133. doi: 10.1182/blood-2018-03-841171. Epub 2018 Jul 25. Blood. 2018. PMID: 30045838 Free PMC article. Clinical Trial.

9

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.

Stein EM, Walter RB, Erba HP, Fathi AT, Advani AS, Lancet JE, Ravandi F, Kovacsovics T, DeAngelo DJ, Bixby D, Faderl S, Jillella AP, Ho PA, O'Meara MM, Zhao B, Biddle-Snead C, Stein AS. Stein EM, et al. Among authors: o meara mm. Blood. 2018 Jan 25;131(4):387-396. doi: 10.1182/blood-2017-06-789800. Epub 2017 Dec 1. Blood. 2018. PMID: 29196412 Free PMC article. Clinical Trial.

10

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo.

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML. Cecil DL, et al. Among authors: o meara mm. Clin Cancer Res. 2017 Jul 1;23(13):3396-3404. doi: 10.1158/1078-0432.CCR-16-1678. Epub 2016 Dec 30. Clin Cancer Res. 2017. PMID: 28039264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page